Mercury Pharmaceuticals

Trans-tympanic optical stimulation of the cochlea evokes reliable auditory responses

A new study, using Mongolian gerbils as an animal model, demonstrated for the first time that trans-tympanic infrared laser stimulation of the cochlea evokes reliable, auditory-guided behaviour in awake animals without the need for genetic modification or invasive surgical implantation.

A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery

AMT Medical B.V., a clinical-stage Dutch medical technology company, today announced that the one-year results of the SAFE-CAB II clinical trial have been published in The Journal of Thoracic and Cardiovascular Surgery.

Bundibugyo Virus Disease outbreak

As of 14 July, 2,093 confirmed cases of Bundibugyo Virus Disease and 798 deaths had been reported in the DRC and Uganda. A total of 394 people have recovered.

Scientists discover master regulator gene network behind complex psychiatric disorders

A study by the University of Barcelona has identified nearly 20 genes that could contribute to some people being more susceptible to depression, anxiety and traits such as irritability and neuroticism.

COVID lockdown babies show language strengths at age four

Research from the BICYCLE study shows 4-year-olds born in lockdown excel in language but face challenges in executive function, indicating a need for support.

Dexamphetamine and methylphenidate work similarly for ADHD but differ in weight effects

A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences in weight management over time.

Diet helps people lose weight regardless of genetic obesity risk

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.

Leica Biosystems to acquire StatLab

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX platform across India.

BYK strengthens its portfolio of measurement and testing instruments

BYK-Gardner USA, a subsidiary of the specialty chemicals group ALTANA, is acquiring perisens GmbH.